IL-17 Regulates CXCL1 mRNA Stability via an AUUUA/Tristetraprolin-Independent Sequence
Open accessThe DOI matches its Crossref record; 53 of the 55 references it cites were found in a registry or an index.
Abstract
IL-17 contributes to inflammatory response in part by promoting enhanced expression of chemokines, such as CXCL1, by prolonging the t(1/2) of this constitutively unstable mRNA. Although IL-17 is a weak stimulus for transcription of the CXCL1 gene, it strongly potentiates message accumulation via stabilization when the mRNA is transcribed in cells stimulated with TNF. In myeloid cells, LPS-induced CXCL1 mRNA stabilization is dependent on AUUUA-containing sequence motifs that are recognized by the RNA binding protein tristetraprolin (TTP). Using deletion and site-specific mutagenesis, we report that IL-17-mediated stabilization of CXCL1 mRNA in nonmyeloid cells depends on a sequence that does not contain the AUUUA motif. Furthermore, a specific two-nucleotide mutation within this region markedly abrogates sensitivity for IL-17-mediated stabilization. Consistent with this finding, the IL-17-sensitive sequence does not exhibit increased instability in the presence of TTP, and CXCL1 mRNA remains unstable and can be stabilized in response to treatment with IL-17 in embryo fibroblasts from mice in which the TTP gene has been deleted. Whereas the RNA binding protein KSRP has been shown to participate in regulating the instability of human CXCL8 mRNA, inhibitory RNA-based reduction in KSRP does not effect the instability mediated by the IL-17-sensitive sequence motif. These findings suggest that IL-17-mediated chemokine mRNA stabilization in nonmyeloid cells uses a mechanism that is distinct from that operating to control AU-rich mRNA stability in myeloid cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tristretrapolin (TTP) is one of the best characterized RNA-stabilizing proteins in the immune system, but surprisingly does not participate in IL-17-mediated signaling”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Datta et al., 2010
Experimental — accuracy not yet measuredIn the citing paper
“The IL-17-driven pathway that controls RNA stability is initiated by phosphorylation of Act1 by Ikki (IKKe), directing its association to TRAF2 and TRAF5. and mobilizing multiple RBPs”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Datta et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gherzi, R., Trabucchi, M., Ponassi, M., Ruggiero, T., Corte, G., Moroni, C., Chen, C.-Y., Khabar, K. S., Andersen, J. S., & Briata, P. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0050005 · Cited by 148
RetractedAU-rich elements: characterization and importance in mRNA degradation
Chen, C.-Y. A., & Shyu, A.-B. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89102-1 · Cited by 1,948 · cited 2×
“Although these studies have frequently identified the canonical AUUUA sites as critical to promoting rapid mRNA degradation, there are also multiple examples of both noncanonical AREs and non-ARE motifs that can confer instability (15, 26, 28, 29, 45).”
BackgroundThe Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation
Ouyang, W., Kolls, J. K., & Zheng, Y. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.004 · Cited by 1,700 · cited 2×
“The magnitude of NFkB and the associated transcriptional response to IL-17 is, however, modest by comparison with other well-studied proinflammatory cytokine signals (6, 7).”
BackgroundYe, P., Rodriguez, F. H., Kanaly, S., Stocking, K. L., Schurr, J., Schwarzenberger, P., Oliver, P., Huang, W., Zhang, P., Zhang, J., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.519 · Cited by 1,521
The highways and byways of mRNA decay
Garneau, N. L., Wilusz, J., & Wilusz, C. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2104 · Cited by 1,294
Feedback Inhibition of Macrophage Tumor Necrosis Factor-α Production by Tristetraprolin
Carballo, E., Lai, W. S., & Blackshear, P. J. (1998) · Science · doi:10.1126/science.281.5379.1001 · Cited by 1,161 · cited 2×
“These include mRNAs encoding COX2, CXCL8, and GM-CSF.”
BackgroundWinzen, R. (1999) · The EMBO Journal · doi:10.1093/emboj/18.18.4969 · Cited by 777
Lai, W. S., Carballo, E., Strum, J. R., Kennington, E. A., Phillips, R. S., & Blackshear, P. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.4311 · Cited by 729 · cited 1×
“The ability of IL-17 to prolong TNF-induced CXCL1 expression is seen largely in nonmyeloid cell populations where TTP expression could be relatively low (21, 38, 39).”
BackgroundQian, Y., Liu, C., Hartupee, J., Altuntas, C. Z., Gulen, M. F., Jane-wit, D., Xiao, J., Lu, Y., Giltiay, N., Liu, J., et al. (2007) · Nature Immunology · doi:10.1038/ni1439 · Cited by 614 · cited 2×
“The magnitude of NFkB and the associated transcriptional response to IL-17 is, however, modest by comparison with other well-studied proinflammatory cytokine signals (6, 7).”
BackgroundResultSelf-citationDecay Rates of Human mRNAs: Correlation With Functional Characteristics and Sequence Attributes
Yang, E., van Nimwegen, E., Zavolan, M., Rajewsky, N., Schroeder, M., Magnasco, M., & Darnell, J. E. (2003) · Genome Research · doi:10.1101/gr.1272403 · Cited by 606
Cited by
Lowes, M. A., Suárez-Fariñas, M., & Krueger, J. G. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120225 · Cited by 1,650
“In this manner, Th1 activation, leading to increased production of IFN-γ, induces synthesis of chemokines (CXCL9, CXCL10, and CXCL11) that can recruit more Th1 cells.”
BackgroundInfluentialThe IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“These RBPs bind 3’ UTR motifs and counteracting the activity of de-stabilizing ribonucleases (see below) (Amatya et al., 2018; Herjan et al., 2013; Puel and Casanova, 2018).”
BackgroundInfluentialIL-17 Signaling: The Yin and the Yang
Amatya, N., Garg, A. V., & Gaffen, S. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.006 · Cited by 785
“For example, tristetraprolin (TTP), one of the best-characterized AU-rich element (ARE)-binding factors known to be activated by IL-1β and TNFα, does not stabilize mRNA in response to IL-17 [86].”
BackgroundGriffin, G. K., Newton, G., Tarrio, M. L., Bu, D.-X., Maganto-Garcia, E., Azcutia, V., Alcaide, P., Grabie, N., Luscinskas, F. W., Croce, K. J., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200385 · Cited by 364
The Immunopathogenesis of Psoriasis
Kim, J., & Krueger, J. G. (2015) · Dermatologic Clinics · doi:10.1016/j.det.2014.09.002 · Cited by 331
Recent advances in the IL-17 cytokine family
Gaffen, S. L. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.006 · Cited by 283
Sun, D., Novotny, M., Bulek, K., Liu, C., Li, X., & Hamilton, T. (2011) · Nature Immunology · doi:10.1038/ni.2081 · Cited by 232
Self-citationBulek, K., Liu, C., Swaidani, S., Wang, L., Page, R. C., Gulen, M. F., Herjan, T., Abbadi, A., Qian, W., Sun, D., et al. (2011) · Nature Immunology · doi:10.1038/ni.2080 · Cited by 192
Self-citationIL‐17: overview and role in oral immunity and microbiome
Abusleme, L., & Moutsopoulos, N. (2017) · Oral Diseases · doi:10.1111/odi.12598 · Cited by 183
Yan, X., Shichita, T., Katsumata, Y., Matsuhashi, T., Ito, H., Ito, K., Anzai, A., Endo, J., Tamura, Y., Kimura, K., et al. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.004408 · Cited by 164
“IL-17A isknown topromote theexpressionof CXCL1 by inducing gene transcription and posttranscriptional stabilization ofmRNA infibroblasts.(44,45)Neutrophils accumulating”
BackgroundKorbecki, J., Barczak, K., Gutowska, I., Chlubek, D., & Baranowska‐Bosiacka, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020792 · Cited by 173
“The AUUUA motifs on the 3′-UTR also act to reduce the stability of CXCL1 mRNA [42].”
BackgroundDendritic epidermal T cells regulate skin antimicrobial barrier function
MacLeod, A. S., Hemmers, S., Garijo, O., Chabod, M., Mowen, K., Witherden, D. A., & Havran, W. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70064 · Cited by 152
“Findings from this study and others demonstrate that IL-17A induces not only inflammatory but also proliferative cell responses (38, 59) and exerts effects on various genes relevant for wound healing including β -defensins, Reg proteins, CXCL1, and matrix metalloproteinases (59, 77–79).”
Garg, A. V., Amatya, N., Chen, K., Cruz, J. A., Grover, P., Whibley, N., Conti, H. R., Hernandez Mir, G., Sirakova, T., Childs, E. C., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.021 · Cited by 145
“Consistently, a mIL-17RA Immunity 43, 1–13, September 15, 2015 ª2015 Elsevier Inc. 5 2.5 2.0 1.5 1.0 0.5 0 C lin ic al S co re Day 1 4 7 10 13 16 19 22 Zc3h12a+/+Il17ra-/- Zc3h12a+/-Il17ra+/+ Zc3h12a+/+Il17ra+/+ * * * * * * Day 1 4 7 10 13 16 19 22 0 80 60 40 20% In ci de nc e A B Cxcl10.”
InfluentialChen, J., Ye, X., Pitmon, E., Lu, M., Wan, J., Jellison, E. R., Adler, A. J., Vella, A. T., & Wang, K. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0757-z · Cited by 144
The deubiquitinase A20 mediates feedback inhibition of interleukin-17 receptor signaling
Garg, A. V., Ahmed, M., Vallejo, A. N., Ma, A., & Gaffen, S. L. (2013) · Science Signaling · doi:10.1126/scisignal.2003699 · Cited by 128
Herjan, T., Hong, L., Bubenik, J., Bulek, K., Qian, W., Liu, C., Li, X., Chen, X., Yang, H., Ouyang, S., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0071-9 · Cited by 121
“To test such a possibility, we subjected Act1 SEFIR and IL-17RA SEFIR to RNA electrophoretic mobility shift assay (REMSA) on Cxcl1 3’UTR, which was shown to be regulated by the IL-17-Act1-axis for stabilization of Cxcl1 mRNA 25, 26 .”
Self-citationTsai, H.-C., Velichko, S., Hung, L.-Y., & Wu, R. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/267971 · Cited by 117
“In this review, we summarize the recent advances in unraveling the mechanism behindTh17 cell differentiation, IL-17A/IL-17R signaling, and also the importance of IL-17A in pulmonary infection.”
BackgroundRoussel, P., Cunha, P., Porcherie, A., Petzl, W., Gilbert, F. B., Riollet, C., Zerbe, H., Rainard, P., & Germon, P. (2015) · Veterinary Research · doi:10.1186/s13567-015-0201-4 · Cited by 93
Liu, W. (2010) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2010.10.004 · Cited by 100
Amatya, N., Childs, E. E., Cruz, J. A., Aggor, F. E. Y., Garg, A. V., Berman, A. J., Gudjonsson, J. E., Atasoy, U., & Gaffen, S. L. (2018) · Science Signaling · doi:10.1126/scisignal.aat4617 · Cited by 75
Song, M., Liang, J., Wang, L., Li, W., Jiang, S., Xu, S., Tang, L., Du, Q., Liu, G., Meng, H., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110757 · Cited by 74
IL-17: Balancing Protective Immunity and Pathogenesis
Sun, L., Wang, L., Moore, B. B., Zhang, S., Xiao, P., Decker, A. M., & Wang, H. (2023) · Journal of Immunology Research · doi:10.1155/2023/3360310 · Cited by 78
Molecular pathways: hepatitis C virus, CXCL10, and the inflammatory road to liver cancer
Brownell, J., & Polyak, S. J. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0928 · Cited by 70
Li, S., Na, R., Li, X., Zhang, Y., & Zheng, T. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188758 · Cited by 74
Carrillo-Salinas, F. J., Navarrete, C., Mecha, M., Feliú, A., Collado, J. A., Cantarero, I., Bellido, M. L., Muñoz, E., & Guaza, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094733 · Cited by 66
“If this were the case, IL-17 released in CD3/CD28-stimulated T cells could act in an autocrine manner, increasing the stability of other CD3/CD28induced cytokine mRNAs, an activity that could also be inhibited by VCE-003 [30,31].”
BackgroundInterleukin-23-Mediated Inflammation in Pseudomonas aeruginosa Pulmonary Infection
Dubin, P. J., Martz, A., Eisenstatt, J. R., Fox, M. D., Logar, A., & Kolls, J. K. (2011) · Infection and Immunity · doi:10.1128/iai.05821-11 · Cited by 68
“aeruginosa pulmonary infection and does not promote concurrent inflammation during early infection, the IL-17 produced during the innate immune response may serve to prolong the inflammatory response through stabilization of chemokine mRNA and G-CSF production (11, 26, 53) or by producing the conditions that foster th…”
BackgroundNetworks controlling mRNA decay in the immune system
Schott, J., & Stoecklin, G. (2010) · WIREs RNA · doi:10.1002/wrna.13 · Cited by 63
Sparna, T., Rétey, J., Schmich, K., Albrecht, U., Naumann, K., Gretz, N., Fischer, H., Bode, J. G., & Merfort, I. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-226 · Cited by 66
Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases
Nirula, A., Nilsen, J., Klekotka, P. A., Kricorian, G., Erondu, N., Towne, J. E., Russell, C. B., Martin, D. A., & Budelsky, A. (2016) · Rheumatology · doi:10.1093/rheumatology/kew346 · Cited by 63
Xia, W., Bai, J., Wu, X., Wei, Y. Z., Feng, S., Li, L., Zhang, J., Xiong, G., Fan, Y., Shi, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098915 · Cited by 60
Anti-CXCL5 therapy ameliorates IL-17-induced arthritis by decreasing joint vascularization
Pickens, S. R., Chamberlain, N. D., Volin, M. V., Gonzalez, M. H., Pope, R. M., Mandelin, A. M., Kolls, J. K., & Shahrara, S. (2011) · Angiogenesis · doi:10.1007/s10456-011-9227-z · Cited by 54
“In nonmyeloid cells IL-17-induced stabilization of CXCL1 is independent of AUUUA motif [40] however activator of NF-kappaB1 protein (Act1) is required for this process[41].”
BackgroundCao, H., Sethumadhavan, K., Cao, F., & Wang, T. T. Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-84970-8 · Cited by 49
Varikuti, S., Oghumu, S., Elbaz, M., Volpedo, G., Ahirwar, D. K., Alarcon, P. C., Sperling, R. H., Moretti, E., Pioso, M. S., Kimble, J., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1361088 · Cited by 41
“Previous studies have shown that CXCL1 enhances accumulation of CD11bCLy6GC cells into the tumors which promotes tumor cell survival,(31) and that IL-17 is an important cytokine for CXCL1 induction.(40,41) In the present study, we found that Cxcl1 expression was increased in the tumors of STAT1¡/¡ mice in an IL-17 dep…”
IRAK2 directs stimulus-dependent nuclear export of inflammatory mRNAs
Zhou, H., Bulek, K., Li, X., Herjan, T., Yu, M., Qian, W., Wang, H., Zhou, G., Chen, X., Yang, H., et al. (2017) · eLife · doi:10.7554/elife.29630 · Cited by 38
“Using Cxcl1 3’UTR (nt 781–901, which contains stimulus-sensitive motifs (Datta et al., 2010; Hartupee et al., 2007), we validated the SRSF1 binding to this transcript by RNA electrophoretic mobility shift assay (REMSA) (Figure 6A).”
MethodSelf-citationDiversity in post-transcriptional control of neutrophil chemoattractant cytokine gene expression
Hamilton, T., Novotny, M., Pavicic, P. J., Herjan, T., Hartupee, J., Sun, D., Zhao, C., & Datta, S. (2010) · Cytokine · doi:10.1016/j.cyto.2010.04.003 · Cited by 36
Self-citationGriseri, P., & Pagès, G. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0140 · Cited by 36
Takeuchi, O. (2017) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1449 · Cited by 37
Hamilton, T., Li, X., Novotny, M., Pavicic, P. G., Datta, S., Zhao, C., Hartupee, J., & Sun, D. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0811404 · Cited by 32
“of CXCL1(KC), which does not contain AUUUA motifs [85].”
BackgroundSelf-citationCoordinated Post-Transcriptional Regulation of the Chemokine System: Messages from CCL2
Panganiban, R. P., Vonakis, B. M., Ishmael, F. T., & Stellato, C. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0149 · Cited by 33
Catar, R. A., Chen, L., Cuff, S. M., Kift-Morgan, A. P., Eberl, M., Kettritz, R., Kamhieh‐Milz, J., Moll, G., Li, Q., Zhao, H., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5438 · Cited by 36
“The post-transcriptional control is related predominantly to stabilisation of CXCL1mRNA [16,17].”
BackgroundMTG16 contributes to colonic epithelial integrity in experimental colitis
Williams, C. S., Bradley, A. M., Chaturvedi, R., Singh, K., Piazuelo, M. B., Chen, X., McDonough, E. M., Schwartz, D. A., Brown, C. T., Allaman, M. M., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301439 · Cited by 29
Kim, M. H., Jin, S., Jang, S., Choi, J., Chung, D. H., Lee, D. H., Kim, K. H., & Kim, H. Y. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.08.447 · Cited by 29
IL-17R signaling: new players get in on the Act1
May, M. J. (2011) · Nature Immunology · doi:10.1038/ni.2093 · Cited by 25
Epigenetic Regulation of IL-17-Induced Chemokines in Lung Epithelial Cells
Luo, J., An, X., Yao, Y., Erb, C., Ferguson, A. A., Kolls, J. K., Fan, S., & Chen, K. (2019) · Mediators of Inflammation · doi:10.1155/2019/9050965 · Cited by 26
Dhamija, S., Winzen, R., Doerrie, A., Behrens, G., Kühne, N., Schauerte, C., Neumann, E., Dittrich‐Breiholz, O., Kracht, M., & Holtmann, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.452649 · Cited by 28
“We recently reported that IL-1 can activate translation of IL-6 and IL-1 mRNAs, which both contain AREs, by counteracting a translational silencing effect of the ARE-binding protein KSRP (3).”
BackgroundInfluentialBioinformatic Analysis of the CXCR2 Ligands in Cancer Processes
Korbecki, J., Bosiacki, M., Chlubek, D., & Baranowska‐Bosiacka, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713287 · Cited by 24
Bai, W., Wang, Q., Deng, Z., Li, T., Xiao, H. Q., & Wu, Z. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00532-x · Cited by 23
Altieri, A., Piyadasa, H., Hemshekhar, M., Osawa, N., Recksiedler, B., Spicer, V., Hiemstra, P. S., Halayko, A. J., & Mookherjee, N. (2022) · Journal of Inflammation · doi:10.1186/s12950-022-00323-w · Cited by 24
Zhao, L., Wang, Z., Tan, Y., Ma, J., Huang, W., Zhang, X., Jin, C., Zhang, T., Liu, W., & Yang, Y. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115039 · Cited by 22
Zhang, L., Pavicic, P. G., Datta, S., Song, Q., Xu, X., Wei, W., Su, F., Rayman, P. A., Zhao, C., & Hamilton, T. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01390 · Cited by 22
Self-citationYe, X., Chen, J., Pan, J., Wu, Q., Wang, Y., Lu, M., Zhang, C., Zhang, Z., Ma, M., Zhu, J., et al. (2022) · Immunological Investigations · doi:10.1080/08820139.2022.2136525 · Cited by 18
Dessalle, K., Venkatesan, N., Kyoh, S., Mogas, A. K., Halayko, A. J., Nair, P. K., Baglole, C. J., Eidelman, D. H., Ludwig, M. S., & Hamid, Q. A. (2016) · Clinical & Experimental Allergy · doi:10.1111/cea.12744 · Cited by 18
Nagaraj, C., Haitchi, H. M., Heinemann, Á., Howarth, P. H., Olschewski, A., & Marsh, L. M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6863 · Cited by 19
“Infiltration of inflammatory cells, in particular eosinophils and T cells, into the airways and the increased expression of Th2 cytokines (IL-4) (5, 13) lead to enhanced airway smooth muscle contraction manifested as AHR (10, 36).”
Khalid, F., Takagi, K., Sato, A., Yamaguchi, M., Guestini, F., Miki, Y., Miyashita, M., Hirakawa, H., Ohi, Y., Rai, Y., et al. (2023) · Breast Cancer · doi:10.1007/s12282-023-01467-0 · Cited by 17
“However, it is also true that IL-17A can stabilize CXCL1 mRNA [19].”
BackgroundChowdhury, S., Dijkhuis, A., Steiert, S., & Lutter, R. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003747 · Cited by 16
Wang, X., Shields, C. A., Tardo, G. A., Peacock, G., Hester, E., Anderson, M., Williams, J. M., & Cornelius, D. C. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00045.2024 · Cited by 12
RNA binding protein, tristetraprolin in a murine model of recurrent pregnancy loss
Khalaj, K., Luna, R. L., de França, M. E. R., de Oliveira, W. H., Peixoto, C. A., & Tayade, C. (2016) · Oncotarget · doi:10.18632/oncotarget.12539 · Cited by 10
“Primary transcripts that the tristetraprolin family has been found to regulate include: TNF-α [17], granulocytemacrophage colony stimulating factor (GM-CSF) [18], IFN-γ [19], as well as nuclear factor kappa beta (NFκB)[20], and chemokines including CXCL1 [21, 22].”
BackgroundCao, H., & Sethumadhavan, K. (2022) · Molecules · doi:10.3390/molecules27217560 · Cited by 10
“The selection of 55 genes for qPCR analysis was based on the literature showing those gene expressions regulated by TTP, gossypol, or cinnamon extract in cancer cells and macrophages (relevant references are listed in the right column in Table 1).”
BackgroundInfluentialAnalysis of Chemokines and Receptors Expression Profile in the Myelin MutantTaiepRat
Soto-Rodríguez, G., González-Barrios, J. A., Martínez‐Fong, D., Blanco-Álvarez, V. M., Eguibar, J. R., Ugarte, A., Martínez‐Pérez, F., Brambila, E., Peña, L. M.-P., Pazos-Salazar, N. G., et al. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/397310 · Cited by 10
Bacterial endotoxin lipopolysaccharides regulate gene expression in human colon cancer cells
Cao, H. (2023) · BMC Research Notes · doi:10.1186/s13104-023-06506-9 · Cited by 9
“TTP family proteins also regulate the stability of several interleukin (IL) mRNAs coding for IL2 [41], IL6 [42], IL8 [43], IL10 [44], IL12 [45], IL16 [23] and IL17 [46].”
BackgroundThe IL17REL gene encodes a decoy receptor of IL-17 family cytokines to control gut inflammation
Li, Q., Li, X., Lou, Y., Xing, Y., Wei, Y., Chen, Y., Hu, G., Song, X., Liu, Z., Yang, T., et al. (2026) · Nature Immunology · doi:10.1038/s41590-025-02368-4 · Cited by 9
Integrating p38α MAPK immune signals in nonimmune cells
Gaffen, S. L., & McGeachy, M. J. (2015) · Science Signaling · doi:10.1126/scisignal.aaa8398 · Cited by 9
“In this regard, IL-17 mediates stabilization of Cxcl1 mRNA and other chemokine transcripts, although, interestingly, in a TTP-independent manner (8).”
BackgroundXin, C., Chen, Z., Zhou, J., Chen, Y., Liu, Y., Liu, H., Liang, C., Zhu, X., Qi, Y., Wang, A., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140057 · Cited by 6
Diversity in sequence-dependent control of GRO chemokine mRNA half-life
Herjan, T., Novotny, M., & Hamilton, T. A. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0812370 · Cited by 6
“For example, we have determined recently that the mCXCL1 mRNA has multiple distinct sequence regions that control instability and sensitivity to proinflammatory stimuli that operate distinctly in myeloid cell types and in nonmyeloid cells, including fibroblasts and epithelial cells [21, 22].”
BackgroundResultSelf-citationAct1 drives chemoresistance via regulation of antioxidant RNA metabolism and redox homeostasis
Hong, L., Herjan, T., Chen, X., Zagore, L. L., Bulek, K., Wang, H., Yang, C. J., Licatalosi, D. D., Li, X., & Li, X. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20231442 · Cited by 5
“…because of conserved cis-elements within the 3 9 untranslated regions (UTRs) that can be recognized by RNA-binding proteins (including TTP [Datta et al., 2010; Tiedje et al., 2016], AUF1 [Abbadi et al., 2019; Sun et al., 2016], KSRP [Bollmann et al., 2014; Schmidtke et al., 2019], SF2…”
Self-citationJiang, T., Li, S., Tang, L., Tan, Y., & Ouyang, W. (2024) · Central European Journal of Immunology · doi:10.5114/ceji.2024.145013 · Cited by 5
Cottonseed extracts regulate gene expression in human colon cancer cells
Cao, H., Sethumadhavan, K., Wu, X., Zeng, X., & Zhang, L. (2022) · Scientific Reports · doi:10.1038/s41598-022-05030-3 · Cited by 5
K-Homology Type Splicing Regulatory Protein: Mechanism of Action in Cancer and Immune Disorders
Leavenworth, J. D., Yusuf, N., & Hassan, Q. (2023) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.2023048085 · Cited by 4
Nowotarski, S. L., & Shantz, L. M. (2017) · Medical Sciences · doi:10.3390/medsci6010002 · Cited by 3
Role of IL-23, IL-17, and IL-22 in Psoriasis
Sabat, R., & Wolk, K. (2012) · Springer eBooks · doi:10.1007/978-3-0348-0522-3_21 · Cited by 2
Psoriasis and Other Skin Inflammatory Diseases
Kim, J., & Krueger, J. G. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch41 · Cited by 2
Structure and IL-17 Receptor Signaling
Tsang, M., & Gaffen, S. L. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9371-7_9
Furlong, S. J. (2012) · Library and Archives Canada (Government of Canada)
Interplay between Pathogenic and Immune Regulatory Mechanisms in G-alpha-i2 deficient colitis
Götlind, Y.-Y. C. (2011) · Gothenburg University Publications Electronic Archive (Gothenburg University)
FEEDBACK INHIBITION OF IL-17 RECEPTOR SIGNAL TRANSDUCTION
Garg, A. V. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
mRNA Destabilizing Factor TTP Expression at the Porcine Maternal- Fetal Interface
Khalaj, K. (2013) · The Atrium (University of Guelph)
Signal Transduction and TH17 Cell Differentiation
Yang, X., O’Shea, J. J., Ghoreschi, K., & Laurence, A. D. J. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9371-7_8 · Cited by 1
Caracterização da sinalização via IL-1R durante a infecção experimental por Leishmania infantum
Oliveira, P. A. S. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2017.tde-30032017-135957
Gaffen, S. L. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.13199957.14542080
Gaffen, S. L., & Amatya, N. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732887195.793546043
Altieri, A., Piyadasa, H., Hemshekhar, M., Osawa, N., Recksiedler, B., Spicer, V., Hiemstra, P. S., Halayko, A. J., & Mookherjee, N. (2023) · Figshare · doi:10.6084/m9.figshare.22607563
Zhao, L., Sheng, L., Qiu, J., Ma, J., Jin, K., Zhao, B., Miao, T., Chen, J., Li, Y., Zhang, Z., et al. (2026) · Advanced Science · doi:10.1002/advs.202519836
Miralles, C. M., Manousakis, E., Moreta-Moraleda, C., Baccara, H., Mahon, L., Franquet, L. L., Albó, M. M. I., Pujolà, A. T., Ferrari, R., & Wright, R. H. G. (2026) · Research Square · doi:10.21203/rs.3.rs-9982165/v1
Wang, T., Lei, C., Xu, Z., Song, X., Tuohongerbieke, A., Jones, T., Kong, M., Hao, C., Chen, Z., Tan, Y., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-78800-6
Metadata
- Authors
- Datta, S., Novotny, M., Pavicic, P. G., Zhao, C., Herjan, T., Hartupee, J., & Hamilton, T.
- Affiliations
- Cleveland Clinic (US)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-12-30
- Volume
- 184
- Issue
- 3
- Pages
- 1484-1491
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC2829999
- OpenAlex
- W2142784097
- Cited by
- 82
- References
- 55
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 3 · 2023: 7 · 2022: 6 · 2021: 1 · 2020: 2 · 2019: 5 · 2018: 3 · 2017: 8 · 2016: 4 · 2015: 4 · 2014: 7 · 2013: 8 · 2012: 5
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- United States Public Health Service (CA39621, CA62220)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- IL-17, CXCL1, mRNA stability, AUUUA motif, tristetraprolin, AU-rich elements, KSRP, TNF-α, embryonic fibroblasts
- MeSH terms
- Animals, Base Sequence, Cell Line, Cells, Cultured, HeLa Cells, Humans, Molecular Sequence Data, RNA, Messenger, Mutagenesis, Site-Directed, Zinc Fingers, RNA-Binding Proteins, Transgenes, Interleukin-17, 3' Untranslated Regions, RNA Stability, Mice, Tristetraprolin, Chemokine CXCL1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.